Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

American Journal of Hematology
Francesca GayRuben Niesvizky

Abstract

The objective of this case-matched study was to compare the efficacy and toxicity of the addition of clarithromycin (Biaxin) to lenalidomide/low-dose dexamethasone (BiRd) vs. lenalidomide/low-dose dexamethasone (Rd) for newly diagnosed myeloma. Data from 72 patients treated at the New York Presbyterian Hospital-Cornell Medical Center were retrospectively compared with an equal number of matched pair mates selected among patients seen at the Mayo Clinic who received Rd. Case matching was blinded and was performed according to age, gender, and transplant status. On intention-to-treat analysis, complete response (45.8% vs. 13.9%, P < 0.001) and very-good-partial-response or better (73.6% vs. 33.3%, P < 0.001) were significantly higher with BiRd. Time-to-progression (median 48.3 vs. 27.5 months, P = 0.071), and progression-free survival (median 48.3 vs. 27.5 months, P = 0.044) were higher with BiRd. There was a trend toward better OS with BiRd (3-year OS: 89.7% vs. 73.0%, P = 0.170). Main grade 3-4 toxicities of BiRd were hematological, in particular thrombocytopenia (23.6% vs. 8.3%, P = 0.012). Infections (16.7% vs. 9.7%, P = 0.218) and dermatological toxicity (12.5% vs. 4.2%, P = 0.129) were higher with Rd. Results of this case-m...Continue Reading

Associated Clinical Trials

References

Feb 1, 1990·American Journal of Hematology·R AlexanianS Tucker
Jan 5, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J D SpahnD Y Leung
Mar 20, 2004·Lancet·Bhawna Sirohi, Ray Powles
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Jan 25, 2008·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Oct 4, 2008·The New England Journal of Medicine·Daniel Steinberg

❮ Previous
Next ❯

Citations

Jun 9, 2012·Leukemia·D H VesoleUNKNOWN University of Rochester Cancer Center and the Eastern Cooperative Oncology Group
Oct 13, 2011·Surgical Infections·Samuel SultanPhilip S Barie
Jan 25, 2012·Current Opinion in Oncology·Cristina JoãoHelena Figueira Martins
Nov 8, 2012·Future Oncology·Alessandra LaroccaAntonio Palumbo
Jun 27, 2014·BioMed Research International·Alessandra RomanoFrancesco Di Raimondo
Aug 25, 2012·Advances in Hematology·Roberta MartinianiAnna Marina Liberati
Feb 1, 2012·Leukemia & Lymphoma·Jessica K Altman, Leonidas C Platanias
Aug 30, 2014·Expert Opinion on Biological Therapy·Claudia Andreu-Vieyra, James R Berenson
Jul 17, 2012·Pharmacology & Therapeutics·Beiqing Pan, Suzanne Lentzsch
Apr 12, 2014·American Journal of Hematology·Nilanjan GhoshCarol Ann Huff
Apr 11, 2015·Future Oncology·María J Cejalvo, Javier de la Rubia
Jul 4, 2018·Leukemia & Lymphoma·Meletios A Dimopoulos, Efstathios Kastritis
Aug 4, 2018·Annals of Hematology·Nicholas Burwick, Sanjai Sharma
Apr 29, 2015·Oncotarget·Salvador AlonsoGabriel Ghiaur
May 1, 2013·Leukemia Supplements·S Girnius, N C Munshi
May 11, 2018·Journal of Medical Case Reports·Kern Y ChaiIan M Morison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.